Biosenic SA
0.0060
10-一月-25 04:19:19
15 分钟延时
股票
+0.0002
+3.45%
今日范围
0.0059 - 0.0060
ISIN
BE0974280126
来源
Cboe
-
30 8月 2021 00:00:00 条件 Nasdaq GlobeNewswire
-
Bone Therapeutics SA: Notice of Extraordinary Shareholders’ Meeting on 23 August 2021
06 8月 2021 00:00:00 条件 Nasdaq GlobeNewswire
-
27 7月 2021 12:00:00 条件 Nasdaq GlobeNewswire
-
Bone Therapeutics provides update on the progress of clinical studies
19 7月 2021 00:00:00 条件 Nasdaq GlobeNewswire
-
Bone Therapeutics appoints Anne Leselbaum, MD as Chief Medical Officer
12 7月 2021 00:00:00 条件 Nasdaq GlobeNewswire
-
Bone Therapeutics SA: Notice of Extraordinary Shareholders’ Meeting on 5 August 2021
05 7月 2021 00:00:00 条件 Nasdaq GlobeNewswire
-
30 6月 2021 00:00:00 条件 Nasdaq GlobeNewswire
-
Bone Therapeutics announces Annual General Meeting results
10 6月 2021 00:00:00 条件 Nasdaq GlobeNewswire
-
Bone Therapeutics Provides First Quarter 2021 Business Update
26 5月 2021 00:00:00 条件 Nasdaq GlobeNewswire
-
Bone Therapeutics to participate in upcoming conferences
20 5月 2021 00:00:00 条件 Nasdaq GlobeNewswire
-
Bone Therapeutics to host Annual General Meeting on 9 June 2021
07 5月 2021 00:00:00 条件 Nasdaq GlobeNewswire
-
Bone Therapeutics announces 2020 full year results
29 4月 2021 00:00:00 条件 Nasdaq GlobeNewswire
-
30 3月 2021 00:00:00 条件 Nasdaq GlobeNewswire
-
Bone Therapeutics to present in M Vest LLC and Maxim Group LLC Emerging Growth Virtual Conference
17 3月 2021 01:00:00 条件 Nasdaq GlobeNewswire
-
Bone Therapeutics SA: Notice of Extraordinary Shareholders’ Meeting on 26 February 2021
09 2月 2021 00:00:00 条件 Nasdaq GlobeNewswire
-
Bone Therapeutics provides fourth quarter 2020 business update and 2021 outlook
20 1月 2021 00:00:00 条件 Nasdaq GlobeNewswire
-
Bone Therapeutics and Rigenerand sign partnership for cell therapy process development
14 1月 2021 00:00:00 条件 Nasdaq GlobeNewswire
-
Bone Therapeutics treats first patient in ALLOB Phase IIb tibial fracture study
12 1月 2021 00:00:00 条件 Nasdaq GlobeNewswire